CBIO vs KALV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CBIO

45.7
AI Score
VS
KALV Wins

KALV

57.1
AI Score

Investment Advisor Scores

CBIO

46score
Recommendation
HOLD

KALV

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CBIO KALV Winner
Forward P/E 0 25.4453 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 30.7% KALV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.7/100 57.1/100 KALV
Profit Margin 0.0% -118.7% CBIO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CBIO 1M: -15.3% · 3M: -35.3% KALV 1M: +1.1% · 3M: +48.0%

Current Technical Phase

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.7%), weak momentum, RSI 39

RSI (14): 38.5 · Price: $14.47

KALV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (19.4% over 20 days), RSI 76

RSI (14): 76.0 · Price: $27.00

Fundamentals Snapshot

Metric CBIO KALV
Market Cap
Forward P/E -4.9 -9.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin 1.0% 0.5%
Operating Margin -23.8% -0.6%
EPS -5.97 -3.94
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, KALV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.